Appelhans K, Najeeullah R, Frankos V. A correction of misinformation regarding Herbalife. World J Hepatol 2013; 5(10): 601-602 [PMID: 24179622 DOI: 10.4254/wjh.v5.i10.601]
Corresponding Author of This Article
Kristy Appelhans, ND, Director, Department of Global Product Science Safety and Compliance, Herbalife International of America Inc, 990 W 190th Street Suite 650, Torrance, CA 90502, United States. kristyr@herbalife.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letters To The Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/